ReviewNeuroscience bulletin2024

Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil.

Peng-Peng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.